查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1529836

全球戊型肝炎診斷測試市場：市場規模、佔有率、趨勢分析 - 按類型、最終用途、按地區、細分市場預測，2024-2030 年

Hepatitis E Diagnostic Tests Market Size, Share & Trends Analysis Report By Type (ELISA HEV IgM Test, Rapid Diagnostics Test), By End Use (Hospitals, Blood Banks), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

戊型肝炎診斷測試的市場趨勢

預計2023年全球戊型肝炎診斷檢測市場規模將達5,475萬美元，2024年至2030年複合年成長率為4.77%。這一成長歸因於戊型肝炎盛行率的上升、人們對早期檢測必要性的認知不斷提高以及診斷技術的進步。根據世界衛生組織 (WHO) 統計，全球每年約有 2,000 萬人感染戊型肝炎病毒 (HEV)，導致約 330 萬有症狀的戊型肝炎病例。

近年來，全球市場取得了顯著的技術進步，提高了診斷解決方案的準確性、效率和可近性。例如，2021 年 6 月，DiaSorin 宣布推出全自動高通量 CLIA 診斷解決方案。 DiaSorin 的新提案代表了戊型肝炎診斷的重大進步。全自動 CLIA（化學冷光免疫檢測）平台可實現高通量測試，使醫療保健提供者能夠有效篩檢和診斷大量患者。這在戊型肝炎流行率較高的地區尤其重要，快速識別感染者的能力對於有效的疾病控制和預防至關重要。這種先進診斷平台的出現恰逢對準確、高效戊型肝炎檢測解決方案不斷成長的需求。

努力提高醫療保健提供者、高風險族群和公眾的意識對於推動市場成長也很重要。人們對戊型肝炎的風險和後果（包括孕婦死亡率增加）的認知不斷提高，推動了對準確診斷測試的需求。將戊型肝炎檢測納入世界衛生組織 2023 年基本診斷清單眼映了世界對戊型肝炎早期檢測和管理重要性的日益認知。

各國政府和醫療保健系統正在認知到改善監測和疫情管理的必要性，並正在增加 HEV 診斷套件的採購。患者和臨床醫生也要求更多地獲得戊型肝炎檢測，以實現早期診斷和及時治療，進一步推動市場成長。例如，印度政府的國家病毒性肝炎綜合控制計劃旨在透過注重預防、診斷和治療的多方面方法來解決包括戊型肝炎在內的所有形式的病毒性肝炎的負擔。該計劃利用大量政府資金和分散實施策略來加強衛生保健系統有效管理病毒性肝炎的能力。

醫療保健支出的增加，特別是在新興市場，正在支撐市場成長。對早期檢測和有效疾病管理的日益重視正在增加對診斷測試的需求。隨著人們對疾病的認知不斷增強，人們開始重視實施個人衛生、安全水源、良好衛生習慣和食品安全等預防措施，以減少病毒的傳播。

全球戊型肝炎診斷測試市場報告細分

該報告預測了全球、區域和國家層面的收益成長，並對 2018 年至 2030 年各子區隔的最新行業趨勢進行了分析。在這項研究中，Grand View Research 根據類型、最終用途和地區對全球戊型肝炎診斷測試市場報告進行了細分。

  • 類型展望（收益，百萬美元，2018-2030）
  • ELISA HEV IgM 檢測
  • ELISA HEV IgG 檢測
  • 快速診斷測試
  • 聚合酵素鏈鎖反應(PCR)
  • 最終用途展望（收益，百萬美元，2018-2030）
  • 醫院
  • 診斷實驗室
  • 血庫
  • 其他最終用戶
  • 區域展望（收益，百萬美元，2018-2030）
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東/非洲

目錄

第1章調查方法和範圍

第 2 章執行摘要

第 3 章 戊型肝炎診斷檢測市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場推動要素分析
    • 市場限制因素分析
  • 戊型肝炎診斷測試市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析
    • 管道分析

第4章戊型肝炎診斷檢測市場：類型估計和趨勢分析

  • 全球戊型肝炎診斷測試市場：類型儀表板
  • 全球戊型肝炎診斷測試市場：類型分析
  • 全球戊型肝炎診斷測試市場：按類型和收益
  • ELISA HEV IgM 檢測
  • ELISA HEV IgG 測試
  • 快速診斷測試
  • 聚合酵素鏈鎖反應(PCR)

第5章戊型肝炎診斷檢測市場：最終用途估計與趨勢分析

  • 全球戊型肝炎診斷測試市場：最終用途儀表板
  • 全球戊型肝炎診斷測試市場：最終用途變異分析
  • 全球戊型肝炎診斷測試市場：按最終用途分類的收益
  • 醫院
  • 診斷實驗室
  • 血庫
  • 其他用途

第6章戊型肝炎診斷檢測市場：區域估計與趨勢分析

  • 區域儀表板
  • 2018-2030年市場規模、預測趨勢分析：
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東/非洲

第7章 競爭格局

  • 公司/競爭對手分類
  • 供應商情況
    • List of key distributors and channel partners
    • Key customers
    • Key company market share analysis, 2023
    • Wantai BioPharm
    • MP Biomedicals LLP
    • PerkinElmer, Inc
    • DIa.Pro diagnostic Bioprobes srl
    • ELITechGroup
    • Primerdesign Ltd
    • F.Hoffmann-La Roche Ltd
    • Mikrogen GmbH
    • Altona Diagnostics
    • Fortress Diagnostics
Product Code: GVR-4-68040-373-5

Hepatitis E Diagnostic Tests Market Trends

The global hepatitis E diagnostic tests market size was estimated at USD 54.75 million in 2023 and is projected to grow at a CAGR of 4.77% from 2024 to 2030. This growth is attributed to the rising incidences of hepatitis E, increased awareness about the need for early detection, and advancement in diagnostic technologies. According to the World Health Organization (WHO), approximately 20 million people worldwide are infected with the hepatitis E virus (HEV) each year, leading to approximately 3.3 million cases of symptomatic hepatitis E.

The global market has witnessed significant technological advancements in recent years, driving improvements in the accuracy, efficiency, and accessibility of diagnostic solutions. For Instance, in June 2021, DiaSorin introduced the fully automated high-throughput CLIA solution for diagnosis, available in countries that accept the CE market. DiaSorin's new offering represents a significant advancement in hepatitis E diagnostics. The fully automated CLIA (Chemiluminescence Immunoassay) platform enables high-throughput testing, allowing healthcare providers to screen and diagnose many patients efficiently. This is particularly important in regions with a high prevalence of hepatitis E, where the ability to identify infected individuals rapidly is crucial for effective disease management and prevention. The availability of such advanced diagnostic platforms aligns with the growing demand for accurate and efficient hepatitis E testing solutions.

Efforts to raise awareness among healthcare providers, at-risk populations, and the general public are also significant in driving market growth. Greater awareness about the risks and consequences of hepatitis E, such as the higher mortality rates in pregnant women, is fueling the demand for accurate diagnostic tests. The inclusion of hepatitis E tests in the WHO's 2023 Essential Diagnostics List reflects the increasing global recognition of the importance of early detection and management of hepatitis E.

Governments and healthcare systems recognize the need for improved surveillance and outbreak management, leading to increased procurement of HEV diagnostic kits. Patients and clinicians also seek better access to hepatitis E tests to enable early diagnosis and timely treatment, further boosting market growth. For instance, the Government of India comprehensive National Viral Hepatitis Control Program aims to address the burden of all forms of viral hepatitis, including Hepatitis E, through a multi-pronged approach focused on prevention, diagnosis, and treatment. The program involves significant government funding and a decentralized implementation strategy to strengthen the healthcare system's capacity to manage viral hepatitis effectively.

The increasing healthcare expenditure, particularly in emerging markets, is supporting the market growth. The growing emphasis on early detection and effective disease management is driving the demand for diagnostic tests. As awareness about the disease increases, there is a greater focus on implementing preventive measures such as personal hygiene, safe water sources, proper sanitation, and food safety to curb the spread of the virus.

Global Hepatitis E Diagnostic Tests Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global hepatitis E diagnostic tests market report based on type, end use, and region.

  • Type Outlook (Revenue, USD Million, 2018 - 2030)
  • ELISA HEV IgM Test
  • ELISA HEV IgG Test
  • Rapid Diagnostics Test
  • Polymerase Chain Reaction (PCR)
  • End Use Outlook (Revenue, USD Million, 2018 - 2030)
  • Hospital
  • Diagnostics Laboratories
  • Blood Banks
  • Other End User
  • Regional Outlook (Revenue in USD Million, 2018 - 2030)
  • North America

U.S.

Canada

Mexico

  • Europe

UK

Germany

France

Italy

Spain

Denmark

Sweden

Norway

  • Asia Pacific

Japan

China

India

Australia

South Korea

Thailand

  • Latin America

Brazil

Argentina

  • Middle East and Africa

South Africa

Saudi Arabia

UAE

Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. End Use
    • 1.2.3. Regional scope
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Test outlook
    • 2.2.2. End Use outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Hepatitis E Diagnostic Tests Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising incidences of hepatitis E
      • 3.2.1.2. Technological advancements
      • 3.2.1.3. Efforts to raise awareness
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Lack of awareness and access to Hepatitis E testing in developing regions
  • 3.3. Hepatitis E Diagnostic Tests Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape
    • 3.3.3. Pipeline Analysis

Chapter 4. Hepatitis E Diagnostic Tests Market: Treatment Estimates & Trend Analysis

  • 4.1. Global Hepatitis E Diagnostic Tests Market: Type Dashboard
  • 4.2. Global Hepatitis E Diagnostic Tests Market: Type Analysis
  • 4.3. Global Hepatitis E Diagnostic Tests Market by Type, Revenue
  • 4.4. ELISA HEV IgM Test
    • 4.4.1. ELISA HEV IgM Test market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. ELISA HEV IgG Test
    • 4.5.1. ELISA HEV IgG Test market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.6. Rapid Diagnostics Test
    • 4.6.1. Rapid Diagnostics Test market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.7. Polymerase Chain Reaction (PCR)
    • 4.7.1. Polymerase Chain Reaction (PCR) market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Hepatitis E Diagnostic Tests Market: End Use Estimates & Trend Analysis

  • 5.1. Global Hepatitis E Diagnostic Tests Market: End Use Dashboard
  • 5.2. Global Hepatitis E Diagnostic Tests Market: End Use Movement Analysis
  • 5.3. Global Hepatitis E Diagnostic Tests Market Estimates and Forecasts, By End Use, Revenue (USD Million)
  • 5.4. Hospital
    • 5.4.1. Hospital market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Diagnostics Laboratories
    • 5.5.1. Diagnostic Laboratories market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.6. Blood Banks
    • 5.6.1. Blood Banks market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.7. Other End Use
    • 5.7.1. Other End Use market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Hepatitis E Diagnostic Tests Market: Regional Estimates & Trend Analysis by Type and End Use

  • 6.1. Regional Dashboard
  • 6.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 6.3. North America
    • 6.3.1. U.S.
      • 6.3.1.1. Key country dynamics
      • 6.3.1.2. Regulatory framework/ reimbursement structure
      • 6.3.1.3. Competitive scenario
      • 6.3.1.4. U.S. market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.3.2. Canada
      • 6.3.2.1. Key country dynamics
      • 6.3.2.2. Regulatory framework/ reimbursement structure
      • 6.3.2.3. Competitive scenario
      • 6.3.2.4. Canada market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.3.3. Mexico
      • 6.3.3.1. Key country dynamics
      • 6.3.3.2. Regulatory framework/ reimbursement structure
      • 6.3.3.3. Competitive scenario
      • 6.3.3.4. Mexico market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.4. Europe
    • 6.4.1. UK
      • 6.4.1.1. Key country dynamics
      • 6.4.1.2. Regulatory framework/ reimbursement structure
      • 6.4.1.3. Competitive scenario
      • 6.4.1.4. UK market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.4.2. Germany
      • 6.4.2.1. Key country dynamics
      • 6.4.2.2. Regulatory framework/ reimbursement structure
      • 6.4.2.3. Competitive scenario
      • 6.4.2.4. Germany market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.4.3. France
      • 6.4.3.1. Key country dynamics
      • 6.4.3.2. Regulatory framework/ reimbursement structure
      • 6.4.3.3. Competitive scenario
      • 6.4.3.4. France market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.4.4. Italy
      • 6.4.4.1. Key country dynamics
      • 6.4.4.2. Regulatory framework/ reimbursement structure
      • 6.4.4.3. Competitive scenario
      • 6.4.4.4. Italy market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.4.5. Spain
      • 6.4.5.1. Key country dynamics
      • 6.4.5.2. Regulatory framework/ reimbursement structure
      • 6.4.5.3. Competitive scenario
      • 6.4.5.4. Spain market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.4.6. Norway
      • 6.4.6.1. Key country dynamics
      • 6.4.6.2. Regulatory framework/ reimbursement structure
      • 6.4.6.3. Competitive scenario
      • 6.4.6.4. Norway market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.4.7. Sweden
      • 6.4.7.1. Key country dynamics
      • 6.4.7.2. Regulatory framework/ reimbursement structure
      • 6.4.7.3. Competitive scenario
      • 6.4.7.4. Sweden market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.4.8. Denmark
      • 6.4.8.1. Key country dynamics
      • 6.4.8.2. Regulatory framework/ reimbursement structure
      • 6.4.8.3. Competitive scenario
      • 6.4.8.4. Denmark market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Japan
      • 6.5.1.1. Key country dynamics
      • 6.5.1.2. Regulatory framework/ reimbursement structure
      • 6.5.1.3. Competitive scenario
      • 6.5.1.4. Japan market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.5.2. China
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Regulatory framework/ reimbursement structure
      • 6.5.2.3. Competitive scenario
      • 6.5.2.4. China market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.5.3. India
      • 6.5.3.1. Key country dynamics
      • 6.5.3.2. Regulatory framework/ reimbursement structure
      • 6.5.3.3. Competitive scenario
      • 6.5.3.4. India market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.5.4. Australia
      • 6.5.4.1. Key country dynamics
      • 6.5.4.2. Regulatory framework/ reimbursement structure
      • 6.5.4.3. Competitive scenario
      • 6.5.4.4. Australia market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.5.5. South Korea
      • 6.5.5.1. Key country dynamics
      • 6.5.5.2. Regulatory framework/ reimbursement structure
      • 6.5.5.3. Competitive scenario
      • 6.5.5.4. South Korea market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.5.6. Thailand
      • 6.5.6.1. Key country dynamics
      • 6.5.6.2. Regulatory framework/ reimbursement structure
      • 6.5.6.3. Competitive scenario
      • 6.5.6.4. Thailand market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.6. Latin America
    • 6.6.1. Brazil
      • 6.6.1.1. Key country dynamics
      • 6.6.1.2. Regulatory framework/ reimbursement structure
      • 6.6.1.3. Competitive scenario
      • 6.6.1.4. Brazil market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.6.2. Argentina
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Regulatory framework/ reimbursement structure
      • 6.6.2.3. Competitive scenario
      • 6.6.2.4. Argentina market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.7. MEA
    • 6.7.1. South Africa
      • 6.7.1.1. Key country dynamics
      • 6.7.1.2. Regulatory framework/ reimbursement structure
      • 6.7.1.3. Competitive scenario
      • 6.7.1.4. South Africa market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.7.2. Saudi Arabia
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Regulatory framework/ reimbursement structure
      • 6.7.2.3. Competitive scenario
      • 6.7.2.4. Saudi Arabia market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.7.3. UAE
      • 6.7.3.1. Key country dynamics
      • 6.7.3.2. Regulatory framework/ reimbursement structure
      • 6.7.3.3. Competitive scenario
      • 6.7.3.4. UAE market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.7.4. Kuwait
      • 6.7.4.1. Key country dynamics
      • 6.7.4.2. Regulatory framework/ reimbursement structure
      • 6.7.4.3. Competitive scenario
      • 6.7.4.4. Kuwait market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Company/Competition Categorization
  • 7.2. Vendor Landscape
    • 7.2.1. List of key distributors and channel partners
    • 7.2.2. Key customers
    • 7.2.3. Key company market share analysis, 2023
    • 7.2.4. Wantai BioPharm
      • 7.2.4.1. Company overview
      • 7.2.4.2. Financial performance
      • 7.2.4.3. Product benchmarking
      • 7.2.4.4. Strategic initiatives
    • 7.2.5. MP Biomedicals LLP
      • 7.2.5.1. Company overview
      • 7.2.5.2. Financial performance
      • 7.2.5.3. Product benchmarking
      • 7.2.5.4. Strategic initiatives
    • 7.2.6. PerkinElmer, Inc
      • 7.2.6.1. Company overview
      • 7.2.6.2. Financial performance
      • 7.2.6.3. Product benchmarking
      • 7.2.6.4. Strategic initiatives
    • 7.2.7. DIa.Pro diagnostic Bioprobes srl
      • 7.2.7.1. Company overview
      • 7.2.7.2. Financial performance
      • 7.2.7.3. Product benchmarking
      • 7.2.7.4. Strategic initiatives
    • 7.2.8. ELITechGroup
      • 7.2.8.1. Company overview
      • 7.2.8.2. Financial performance
      • 7.2.8.3. Product benchmarking
      • 7.2.8.4. Strategic initiatives
    • 7.2.9. Primerdesign Ltd
      • 7.2.9.1. Company overview
      • 7.2.9.2. Financial performance
      • 7.2.9.3. Product benchmarking
      • 7.2.9.4. Strategic initiatives
    • 7.2.10. F.Hoffmann-La Roche Ltd
      • 7.2.10.1. Company overview
      • 7.2.10.2. Financial performance
      • 7.2.10.3. Product benchmarking
      • 7.2.10.4. Strategic initiatives
    • 7.2.11. Mikrogen GmbH
      • 7.2.11.1. Company overview
      • 7.2.11.2. Financial performance
      • 7.2.11.3. Product benchmarking
      • 7.2.11.4. Strategic initiatives
    • 7.2.12. Altona Diagnostics
      • 7.2.12.1. Company overview
      • 7.2.12.2. Financial performance
      • 7.2.12.3. Product benchmarking
      • 7.2.12.4. Strategic initiatives
    • 7.2.13. Fortress Diagnostics
      • 7.2.13.1. Company overview
      • 7.2.13.2. Financial performance
      • 7.2.13.3. Product benchmarking
      • 7.2.13.4. Strategic initiatives

List of Tables

  • Table 1 List Of Abbreviation
  • Table 2 North America Hepatitis E Diagnostic Tests Market, By Region, 2018 - 2030 (USD Million)
  • Table 3 North America Hepatitis E Diagnostic Tests Market, By Type, 2018 - 2030 (USD Million)
  • Table 4 North America Hepatitis E Diagnostic Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 5 U.S. Hepatitis E Diagnostic Tests Market, By Type, 2018 - 2030 (USD Million)
  • Table 6 U.S. Hepatitis E Diagnostic Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 7 Canada Hepatitis E Diagnostic Tests Market, By Type, 2018 - 2030 (USD Million)
  • Table 8 Canada Hepatitis E Diagnostic Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 9 Mexico Hepatitis E Diagnostic Tests Market, By Type, 2018 - 2030 (USD Million)
  • Table 10 Mexico Hepatitis E Diagnostic Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 11 Europe Hepatitis E Diagnostic Tests Market, By Region, 2018 - 2030 (USD Million)
  • Table 12 Europe Hepatitis E Diagnostic Tests Market, By Type, 2018 - 2030 (USD Million)
  • Table 13 Europe Hepatitis E Diagnostic Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 14 Germany Hepatitis E Diagnostic Tests Market, By Type, 2018 - 2030 (USD Million)
  • Table 15 Germany Hepatitis E Diagnostic Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 16 UK Hepatitis E Diagnostic Tests Market, By Type, 2018 - 2030 (USD Million)
  • Table 17 UK Hepatitis E Diagnostic Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 18 France Hepatitis E Diagnostic Tests Market, By Type, 2018 - 2030 (USD Million)
  • Table 19 France Hepatitis E Diagnostic Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 20 Italy Hepatitis E Diagnostic Tests Market, By Type, 2018 - 2030 (USD Million)
  • Table 21 Italy Hepatitis E Diagnostic Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 22 Spain Hepatitis E Diagnostic Tests Market, By Type, 2018 - 2030 (USD Million)
  • Table 23 Spain Hepatitis E Diagnostic Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 24 Denmark Hepatitis E Diagnostic Tests Market, By Type, 2018 - 2030 (USD Million)
  • Table 25 Denmark Hepatitis E Diagnostic Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 26 Sweden Hepatitis E Diagnostic Tests Market, By Type, 2018 - 2030 (USD Million)
  • Table 27 Sweden Hepatitis E Diagnostic Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 28 Norway Hepatitis E Diagnostic Tests Market, By Type, 2018 - 2030 (USD Million)
  • Table 29 Norway Hepatitis E Diagnostic Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 30 Asia Pacific Hepatitis E Diagnostic Tests Market, By Region, 2018 - 2030 (USD Million)
  • Table 31 Asia Pacific Hepatitis E Diagnostic Tests Market, By Type, 2018 - 2030 (USD Million)
  • Table 32 Asia Pacific Hepatitis E Diagnostic Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 33 China Hepatitis E Diagnostic Tests Market, By Type, 2018 - 2030 (USD Million)
  • Table 34 China Hepatitis E Diagnostic Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 35 Japan Hepatitis E Diagnostic Tests Market, By Type, 2018 - 2030 (USD Million)
  • Table 36 Japan Hepatitis E Diagnostic Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 37 India Hepatitis E Diagnostic Tests Market, By Type, 2018 - 2030 (USD Million)
  • Table 38 India Hepatitis E Diagnostic Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 39 South Korea Hepatitis E Diagnostic Tests Market, By Type, 2018 - 2030 (USD Million)
  • Table 40 South Korea Hepatitis E Diagnostic Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 41 Australia Hepatitis E Diagnostic Tests Market, By Type, 2018 - 2030 (USD Million)
  • Table 42 Australia Hepatitis E Diagnostic Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 43 Thailand Hepatitis E Diagnostic Tests Market, By Type, 2018 - 2030 (USD Million)
  • Table 44 Thailand Hepatitis E Diagnostic Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 45 Latin America Hepatitis E Diagnostic Tests Market, By Region, 2018 - 2030 (USD Million)
  • Table 46 Latin America Hepatitis E Diagnostic Tests Market, By Type, 2018 - 2030 (USD Million)
  • Table 47 Latin America Hepatitis E Diagnostic Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 48 Brazil Hepatitis E Diagnostic Tests Market, By Type, 2018 - 2030 (USD Million)
  • Table 49 Brazil Hepatitis E Diagnostic Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 50 Argentina Hepatitis E Diagnostic Tests Market, By Type, 2018 - 2030 (USD Million)
  • Table 51 Argentina Hepatitis E Diagnostic Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 52 MEA Hepatitis E Diagnostic Tests Market, By Region, 2018 - 2030 (USD Million)
  • Table 53 MEA Hepatitis E Diagnostic Tests Market, By Type, 2018 - 2030 (USD Million)
  • Table 54 MEA Hepatitis E Diagnostic Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 55 South Africa Hepatitis E Diagnostic Tests Market, By Type, 2018 - 2030 (USD Million)
  • Table 56 South Africa Hepatitis E Diagnostic Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 57 Saudi Arabia Hepatitis E Diagnostic Tests Market, By Type, 2018 - 2030 (USD Million)
  • Table 58 Saudi Arabia Hepatitis E Diagnostic Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 59 UAE Hepatitis E Diagnostic Tests Market, By Type, 2018 - 2030 (USD Million)
  • Table 60 UAE Hepatitis E Diagnostic Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 61 Kuwait Hepatitis E Diagnostic Tests Market, By Type, 2018 - 2030 (USD Million)
  • Table 62 Kuwait Hepatitis E Diagnostic Tests Market, By End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Hepatitis E diagnostic tests market outlook
  • Fig. 14 Hepatitis E diagnostic tests competitive insights
  • Fig. 15 Parent market outlook
  • Fig. 16 Related/ancillary market outlook
  • Fig. 17 Hepatitis E diagnostic tests market driver impact
  • Fig. 18 Hepatitis E diagnostic tests market restraint impact
  • Fig. 19 Hepatitis E diagnostic tests market: Type movement analysis
  • Fig. 20 Hepatitis E diagnostic tests market: Type outlook and key takeaways
  • Fig. 21 ELISA HEV IgM test market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 ELISA HEV IgG test market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Rapid Diagnostics test market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Polymerase Chain Reaction (PCR) market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Hepatitis E diagnostic tests market: End Use movement analysis
  • Fig. 26 Hepatitis E diagnostic tests market: End Use outlook and key takeaways
  • Fig. 27 Hospital market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Diagnostic Laboratories market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 Blood Banks market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Other End User market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 Hepatitis E diagnostic tests market: Regional movement analysis
  • Fig. 32 Hepatitis E diagnostic tests market: Regional outlook and key takeaways
  • Fig. 33 Hepatitis E diagnostic tests market share and leading players
  • Fig. 34 North America, by country
  • Fig. 35 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 US key country dynamics
  • Fig. 37 US market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Canada key country dynamics
  • Fig. 39 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Mexico key country dynamics
  • Fig. 41 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 UK key country dynamics
  • Fig. 44 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Germany key country dynamics
  • Fig. 46 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 France key country dynamics
  • Fig. 48 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Italy key country dynamics
  • Fig. 50 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Spain key country dynamics
  • Fig. 52 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Denmark key country dynamics
  • Fig. 54 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Sweden key country dynamics
  • Fig. 56 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Norway key country dynamics
  • Fig. 58 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 China key country dynamics
  • Fig. 61 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Japan key country dynamics
  • Fig. 63 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 India key country dynamics
  • Fig. 65 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Thailand key country dynamics
  • Fig. 67 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 South Korea key country dynamics
  • Fig. 69 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 Australia key country dynamics
  • Fig. 71 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 73 Brazil key country dynamics
  • Fig. 74 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 75 Argentina key country dynamics
  • Fig. 76 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 77 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 78 South Africa key country dynamics
  • Fig. 79 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 80 Saudi Arabia key country dynamics
  • Fig. 81 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 82 UAE key country dynamics
  • Fig. 83 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 84 Kuwait key country dynamics
  • Fig. 85 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 86 Market share of key market players- Hepatitis E Diagnostic Tests market